Rival drugmakers launch joint trial of medicines for COVID-19 – Reuters

Rival drugmakers launch joint trial of medicines for COVID-19 – Reuters

Rival drugmakers AbbVie Inc , Amgen Inc and Takeda Pharmaceuticals Inc on Monday said they have begun treating patients in a trial to quickly show whether a drug from each company can be repurposed and used against COVID-19, the disease caused by the novel co…

Read More…

You May Also Like